# Platelet-rich plasma in arthroscopic rotator cuff repair: a meta-analysis of biomaterial efficacy and future directions for personalized sports medicine

**Authors:** Fan Donghua, Lu Wei, Sun Di, Ying Pu, Wang Qiang, Shen Yingchao, Shi Mingfei, Sun Xin

PMC · DOI: 10.3389/fbioe.2025.1665007 · Frontiers in Bioengineering and Biotechnology · 2026-01-23

## TL;DR

This study finds that platelet-rich plasma (PRP) improves early recovery and pain after rotator cuff surgery, but does not reduce retear rates.

## Contribution

A meta-analysis showing PRP's functional benefits and highlighting the need for standardized protocols and personalized approaches.

## Key findings

- PRP improved functional scores like UCLA and Constant by 1.82 and 2.31 points, respectively.
- PRP reduced pain scores (VAS) by 0.23 points but did not significantly lower retear rates.
- Benefits were strongest for medium/large tears using leukocyte-poor PRP and double-row repairs.

## Abstract

Rotator cuff tears represent a prevalent musculoskeletal challenge with high postoperative retear rates despite surgical advances. Platelet-rich plasma (PRP) has emerged as a promising biological adjunct in arthroscopic repair, though clinical evidence remains inconsistent regarding its efficacy in improving structural and functional outcomes.

This PRISMA-guided meta-analysis evaluated 13 randomized controlled trials (n = 880 patients) comparing PRP-augmented versus conventional arthroscopic rotator cuff repair. Primary outcomes included retear rates and functional scores (UCLA, Constant, SST, ASES, VAS). Statistical analysis employed fixed/random-effects models with subgroup analyses of PRP formulations and tear characteristics.

PRP augmentation significantly improved functional outcomes, with mean differences of 1.82 points (95% CI: 1.13–2.51) for UCLA scores, 2.31 points (95% CI: 1.02–3.61) for Constant scores, and 0.43 points (95% CI: 0.11–0.75) for SST scores (all p < 0.01). VAS pain scores decreased by 0.23 points (95% CI: −0.41 to −0.05, p = 0.01). However, retear rates showed no significant reduction (RR = 0.71, 95% CI: 0.48–1.05, p = 0.09). Benefits were most pronounced in medium/large tears treated with leukocyte-poor PRP and double-row repairs (I2 = 0–40% for functional outcomes). Conclusion: While PRP enhances early functional recovery and pain control after rotator cuff repair, its capacity to improve structural integrity remains unproven. Clinical implementation requires standardization of PRP protocols and targeted application in patients with larger tears. Future research should investigate optimized biomaterial formulations and personalized treatment strategies.

## Full-text entities

- **Diseases:** tears (MESH:D012167), Rotator cuff tears (MESH:D000070636), pain (MESH:D010146)
- **Chemicals:** rich (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877400/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877400/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877400/full.md

---
Source: https://tomesphere.com/paper/PMC12877400